Clinical Trial Update: Safety, Tolerability and Efficacy of the Transdermal System in Elderly Subjects With Major Depression [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating a selegiline transdermal system for safety, tolerability and efficacy in elderly patients with major depressive disorder; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Selegiline transdermal system (selegiline)

Snippet

Sponsor: Somerset Pharmaceuticals | Conditions: Major Depression | Phase 3 | Status: COMPLETED